The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Open accessAbstract
The rapid evolution and dissemination of antibiotic resistance among bacterial pathogens are outpacing the development of new antibiotics, but antivirulence agents provide an alternative. These agents can circumvent antibiotic resistance by disarming pathogens of virulence factors that facilitate human disease while leaving bacterial growth pathways — the target of traditional antibiotics — intact. Either as stand-alone medications or together with antibiotics, these drugs are intended to treat bacterial infections in a largely pathogen-specific manner. Notably, development of antivirulence drugs requires an in-depth understanding of the roles that diverse virulence factors have in disease processes. In this Review, we outline the theory behind antivirulence strategies and provide examples of bacterial features that can be targeted by antivirulence approaches. Furthermore, we discuss the recent successes and failures of this paradigm, and new developments that are in the pipeline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
QUORUM SENSING: Cell-to-Cell Communication in Bacteria
Waters, C. M., & Bassler, B. L. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.012704.131001 · Cited by 3,979
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
Rutherford, S. T., & Bassler, B. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012427 · Cited by 2,129
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Virulence evolution and the trade‐off hypothesis: history, current state of affairs and the future
ALIZON, S., HURFORD, A., MIDEO, N., & VAN BAALEN, M. (2009) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2008.01658.x · Cited by 932
Alpha-toxin of Staphylococcus aureus
Bhakdi, S. C., & Tranum-Jensen, J. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.4.733-751.1991 · Cited by 885
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Bacterial Interference Caused by Autoinducing Peptide Variants
Ji, G., Beavis, R., & Novick, R. P. (1997) · Science · doi:10.1126/science.276.5321.2027 · Cited by 817
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
The changing epidemiology of resistance
Hawkey, P. M., & Jones, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp256 · Cited by 773
Host-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity
Casadevall, A., & Pirofski, L.-A. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3703-3713.1999 · Cited by 769
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
P. aeruginosa quorum-sensing systems and virulence
Smith, R. (2003) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(03)00008-0 · Cited by 704
Bacterial toxins: a table of lethal amounts
Gill, D. M. (1982) · Microbiological Reviews · doi:10.1128/mr.46.1.86-94.1982 · Cited by 629
Interconnected microbiomes and resistomes in low-income human habitats
Pehrsson, E. C., Tsukayama, P., Patel, S., Mejía-Bautista, M., Sosa-Soto, G., Navarrete, K. M., Calderon, M., Cabrera, L., Hoyos-Arango, W., Bertoli, M. T., et al. (2016) · Nature · doi:10.1038/nature17672 · Cited by 607
Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover
Manefield, M., Rasmussen, T. B., Henzter, M., Andersen, J. B., Steinberg, P., Kjelleberg, S., & Givskov, M. (2002) · Microbiology · doi:10.1099/00221287-148-4-1119 · Cited by 604
Zhang, X., McDaniel, A. D., Wolf, L. E., Keusch, G. T., Waldor, M. K., & Acheson, D. W. K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315239 · Cited by 603
Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis
Marvig, R. L., Sommer, L. M., Molin, S., & Johansen, H. K. (2015) · Nature Genetics · doi:10.1038/ng.3148 · Cited by 582
Cospeciation of gut microbiota with hominids
Moeller, A. H., Caro-Quintero, A., Mjungu, D., Georgiev, A. V., Lonsdorf, E. V., Muller, M. N., Pusey, A. E., Peeters, M., Hahn, B. H., & Ochman, H. (2016) · Science · doi:10.1126/science.aaf3951 · Cited by 568
Sorting of protein a to the staphylococcal cell wall
Schneewind, O., Model, P., & Fischetti, V. A. (1992) · Cell · doi:10.1016/0092-8674(92)90101-h · Cited by 552
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Johnson, S., Louie, T. J., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D., Gelone, S. P., Broom, C., Davidson, D. M., & for the Polymer Alternative for CDI Treatment (PACT) investigators (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu313 · Cited by 527
Human Botulism Immune Globulin for the Treatment of Infant Botulism
Arnon, S. S., Schechter, R., Maslanka, S. E., Jewell, N. P., & Hatheway, C. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051926 · Cited by 498
The true cost of antimicrobial resistance
Smith, R., & Coast, J. (2013) · BMJ · doi:10.1136/bmj.f1493 · Cited by 488
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 468
Host‐Pathogen Interactions: The Attributes of Virulence
Casadevall, A., & Pirofski, L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322044 · Cited by 463
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Self-citationMazmanian, S. K., Liu, G., Jensen, E. R., Lenoy, E., & Schneewind, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080520697 · Cited by 453
Dantes, R. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10423 · Cited by 452
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Hasman, H., Hammerum, A. M., Hansen, F., Hendriksen, R. S., Olesen, B., Agersø, Y., Zankari, E., Leekitcharoenphon, P., Stegger, M., Kaas, R. S., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.49.30085 · Cited by 419
Déziel, E., Gopalan, S., Tampakaki, A. P., Lépine, F., Padfield, K. E., Saucier, M., Xiao, G., & Rahme, L. G. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04448.x · Cited by 417
A cell-cell communication signal integrates quorum sensing and stress response
Lee, J., Wu, J., Deng, Y., Wang, J., Wang, C., Wang, J., Chang, C., Dong, Y., Williams, P., & Zhang, L.-H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1225 · Cited by 416
Vandenesch, F., Lina, G., & Henry, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00012 · Cited by 405
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Staphylococcus quorum sensing in biofilm formation and infection
Kong, K.-F., Vuong, C., & Otto, M. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.01.042 · Cited by 388
Self-citationSully, E. K., Malachowa, N., Elmore, B. O., Alexander, S. M., Femling, J. K., Gray, B. M., DeLeo, F. R., Otto, M., Cheung, A. L., Edwards, B. S., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004174 · Cited by 386
Self-citationZogaj, X., Bokranz, W., Nimtz, M., & Römling, U. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.4151-4158.2003 · Cited by 385
ESX secretion systems: mycobacterial evolution to counter host immunity
Gröschel, M. I., Sayes, F., Simeone, R., Majlessi, L., & Brosch, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.131 · Cited by 382
Small-Molecule Inhibitor of Vibrio cholerae Virulence and Intestinal Colonization
Hung, D. T., Shakhnovich, E. A., Pierson, E., & Mekalanos, J. J. (2005) · Science · doi:10.1126/science.1116739 · Cited by 358
Fowler, Jr., Sakoulas, G., McIntyre, L. M., Meka, V. G., Arbeit, R. D., Cabell, C. H., Stryjewski, M. E., Eliopoulos, G. M., Reller, L. B., Corey, G. R., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423145 · Cited by 351
McGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350
Yu, V. L., Hansen, D. S., Ko, W. C., Sagnimeni, A., Klugman, K. P., von Gottberg, A., Goossens, H., Wagener, M. M., Benedi, V. J., & the International Klebsiella Study Group (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.070187 · Cited by 327
Bacterial toxins: a table of lethal amounts.
Dm, G. (1982) · Microbiological Reviews · doi:10.1128/mmbr.46.1.86-94.1982 · Cited by 322
Induction and Inhibition of Pseudomonas aeruginosa Quorum Sensing by Synthetic Autoinducer Analogs
Smith, K. M., Bu, Y., & Suga, H. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00002-4 · Cited by 320
Yuan, Y., Crane, D. D., & Barry, C. E. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.15.4484-4492.1996 · Cited by 318
Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors
Cusumano, C. K., Pinkner, J. S., Han, Z., Greene, S. E., Ford, B. A., Crowley, J. R., Henderson, J. P., Janetka, J. W., & Hultgren, S. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003021 · Cited by 318
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
Theriot, C. M., & Young, V. B. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104115 · Cited by 302
Quorum quenching quandary: resistance to antivirulence compounds
Maeda, T., García-Contreras, R., Pu, M., Sheng, L., Garcia, L. R., Tomás, M., & Wood, T. K. (2012) · The ISME Journal · doi:10.1038/ismej.2011.122 · Cited by 300
Endothelial heterogeneity in Shiga toxin receptors and responses
Obrig, T. G., Louise, C. B., Lingwood, C. A., Boyd, B., Barley-Maloney, L., & Daniel, T. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82282-7 · Cited by 295
Raxibacumab for the Treatment of Inhalational Anthrax
Migone, T.-S., Subramanian, G. M., Zhong, J., Healey, L. M., Corey, A., Devalaraja, M., Lo, L., Ullrich, S., Zimmerman, J., Chen, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810603 · Cited by 294
Exfoliatin-Producing Strains Define a Fourth agr Specificity Group in Staphylococcus aureus
Jarraud, S., Lyon, G. J., Figueiredo, A. M. S., Gérard, L., Vandenesch, F., Etienne, J., Muir, T. W., & Novick, R. P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6517-6522.2000 · Cited by 292
Effects of Antibiotics on Human Microbiota and Subsequent Disease
Keeney, K. M., Yurist-Doutsch, S., Arrieta, M.-C., & Finlay, B. B. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091313-103456 · Cited by 291
Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis
Huycke, M. M., Spiegel, C. A., & Gilmore, M. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1626 · Cited by 283
Identification of a heparin-binding hemagglutinin present in mycobacteria.
Menozzi, F. D., Rouse, J. H., Alavi, M., Laude-Sharp, M., Muller, J., Bischoff, R., Brennan, M. J., & Locht, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.993 · Cited by 281
Isolation and Characterization of an Autoinducer Synthase from Acinetobacter baumannii
Niu, C., Clemmer, K. M., Bonomo, R. A., & Rather, P. N. (2008) · Journal of Bacteriology · doi:10.1128/jb.01929-07 · Cited by 279
Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene
Dover, N., Barash, J. R., Hill, K. K., Xie, G., & Arnon, S. S. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit450 · Cited by 279
MRSA epidemic linked to a quickly spreading colonization and virulence determinant
Li, M., Du, X., Villaruz, A. E., Diep, B. A., Wang, D., Song, Y., Tian, Y., Hu, J., Yu, F., Lu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2692 · Cited by 278
Self-citationA multifunctional bispecific antibody protects against Pseudomonas aeruginosa
DiGiandomenico, A., Keller, A. E., Gao, C., Rainey, G. J., Warrener, P., Camara, M. M., Bonnell, J., Fleming, R., Bezabeh, B., Dimasi, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009655 · Cited by 277
Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005
Holty, J.-E. C., Bravata, D. M., Liu, H., Olshen, R. A., McDonald, K. M., & Owens, D. K. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00009 · Cited by 274
Wong, C. S., Mooney, J. C., Brandt, J. R., Staples, A. O., Jelacic, S., Boster, D. R., Watkins, S. L., & Tarr, P. I. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis299 · Cited by 274
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Foodborne Botulism in the United States, 1990–2000
Sobel, J., Tucker, N., Sulka, A., McLaughlin, J., & Maslanka, S. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1009.030745 · Cited by 261
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01698 · Cited by 258
Babcock, G. J., Broering, T. J., Hernandez, H. J., Mandell, R. B., Donahue, K., Boatright, N., Stack, A. M., Lowy, I., Graziano, R., Molrine, D., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00982-06 · Cited by 257
Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists
Han, Z., Pinkner, J. S., Ford, B., Obermann, R., Nolan, W., Wildman, S. A., Hobbs, D., Ellenberger, T., Cusumano, C. K., Hultgren, S. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100438s · Cited by 236
Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung
Wang, N., Ozer, E. A., Mandel, M. J., & Hauser, A. R. (2014) · mBio · doi:10.1128/mbio.01163-14 · Cited by 234
Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary
Grosset, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.833-836.2003 · Cited by 224
Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1
Åkerlund, T., Persson, I., Unemo, M., Norén, T., Svenungsson, B., Wullt, M., & Burman, L. G. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01964-07 · Cited by 223
Structure, Function, and Biology of the Enterococcus faecalis Cytolysin
Van Tyne, D., Martin, M., & Gilmore, M. (2013) · Toxins · doi:10.3390/toxins5050895 · Cited by 219
Mediavilla, J. R., Patrawalla, A., Chen, L., Chavda, K. D., Mathema, B., Vinnard, C., Dever, L. L., & Kreiswirth, B. N. (2016) · mBio · doi:10.1128/mbio.01191-16 · Cited by 218
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
Kaufmann, S. H. E., Lange, C., Rao, M., Balaji, K. N., Lotze, M., Schito, M., Zumla, A. I., & Maeurer, M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70033-5 · Cited by 217
Abrami, L., Brandi, L., Moayeri, M., Brown, M. J., Krantz, B. A., Leppla, S. H., & van der Goot, F. G. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.019 · Cited by 215
Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria
Carnes, E. C., Lopez, D. M., Donegan, N. P., Cheung, A., Gresham, H., Timmins, G. S., & Brinker, C. J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.264 · Cited by 212
Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I
Walterspiel, J. N., Morrow, A. L., Cleary, T. G., & Ashkenazi, S. (1992) · Infection · doi:10.1007/bf01704889 · Cited by 198
High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess
Lin, J.-C., Chang, F.-Y., Fung, C.-P., Xu, J.-Z., Cheng, H.-P., Wang, J.-J., Huang, L.-Y., & Siu, L. K. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.06.003 · Cited by 196
Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis
Steingart, K. R., Dendukuri, N., Henry, M., Schiller, I., Nahid, P., Hopewell, P. C., Ramsay, A., Pai, M., & Laal, S. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00355-08 · Cited by 191
Covalent Inhibition of Bacterial Quorum Sensing
Amara, N., Mashiach, R., Amar, D., Krief, P., Spieser, S. A. H., Bottomley, M. J., Aharoni, A., & Meijler, M. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903292v · Cited by 188
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Balu, S., Reljic, R., Lewis, M. J., Pleass, R. J., McIntosh, R., van Kooten, C., van Egmond, M., Challacombe, S., Woof, J. M., & Ivanyi, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003189 · Cited by 184
HAMASUR, B., HAILE, M., PAWLOWSKI, A., SCHRÖDER, U., KÄLLENIUS, G., & SVENSON, S. B. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02593.x · Cited by 181
DiGiandomenico, A., Warrener, P., Hamilton, M., Guillard, S., Ravn, P., Minter, R., Camara, M. M., Venkatraman, V., MacGill, R. S., Lin, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120033 · Cited by 174
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
The role of toxin A and toxin B in the virulence of Clostridium difficile
Carter, G. P., Rood, J. I., & Lyras, D. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.003 · Cited by 164
The Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
Mellbye, B., & Schuster, M. (2011) · mBio · doi:10.1128/mbio.00131-11 · Cited by 164
Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase
Zhang, J., Liu, H., Zhu, K., Gong, S., Dramsi, S., Wang, Y.-T., Li, J., Chen, F., Zhang, R., Zhou, L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408601111 · Cited by 164
Lin, L., Tan, B., Pantapalangkoor, P., Ho, T., Baquir, B., Tomaras, A. P., Montgomery, J. I., Reilly, U. D., Barbacci-Tobin, E. G., Hujer, K. M., et al. (2012) · mBio · doi:10.1128/mbio.00312-12 · Cited by 160
Quorum sensing in Acinetobacter: an emerging pathogen
Bhargava, N., Sharma, P., & Capalash, N. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.512269 · Cited by 158
The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD
Sun, J., Siroy, A., Lokareddy, R. K., Speer, A., Doornbos, K. S., Cingolani, G., & Niederweis, M. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3064 · Cited by 153
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
Thangamani, S., Younis, W., & Seleem, M. N. (2015) · Scientific Reports · doi:10.1038/srep11596 · Cited by 151
Rouha, H., Badarau, A., Visram, Z., Battles, M. B., Prinz, B., Magyarics, Z., Nagy, G., Mirkina, I. I., Stulik, L., Zerbs, M., et al. (2014) · mAbs · doi:10.4161/19420862.2014.985132 · Cited by 149
Transfer of Carbapenem-Resistant Plasmid fromKlebsiella pneumoniaeST258 toEscherichia coliin Patient
Goren, M. G., Carmeli, Y., Schwaber, M. J., Chmelnitsky, I., Schechner, V., & Navon‐Venezia, S. (2010) · Emerging infectious diseases · doi:10.3201/eid1606.091671 · Cited by 143
Armstrong, G. D., Rowe, P. C., Goodyer, P., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1042 · Cited by 142
Totsika, M., Kostakioti, M., Hannan, T. J., Upton, M., Beatson, S. A., Janetka, J. W., Hultgren, S. J., & Schembri, M. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit245 · Cited by 139
Kang, B. K., & Schlesinger, L. S. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2769-2777.1998 · Cited by 136
A small-molecule antivirulence agent for treating Clostridium difficile infection
Bender, K. O., Garland, M., Ferreyra, J. A., Hryckowian, A. J., Child, M. A., Puri, A. W., Solow-Cordero, D. E., Higginbottom, S. K., Segal, E., Banaei, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9103 · Cited by 136
Antibacterial Activities of Iron Chelators against Common Nosocomial Pathogens
Thompson, M. G., Corey, B. W., Si, Y., Craft, D. W., & Zurawski, D. V. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-12 · Cited by 135
Schneerson, R., Kübler-Kiełb, J., Liu, T., Dai, Z., Leppla, S. H., Yergey, A. L., Backlund, P. S., Shiloach, J., Majadly, F., & Robbins, J. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633512100 · Cited by 131
Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond
Weber, B. S., Harding, C. M., & Feldman, M. F. (2015) · Journal of Bacteriology · doi:10.1128/jb.00906-15 · Cited by 128
Gerdt, J. P., & Blackwell, H. E. (2014) · ACS Chemical Biology · doi:10.1021/cb5004288 · Cited by 120
Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K. E., Li, P., Zha, J., Chowdury, P., Sellman, B. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 119
Stacy, D. M., Welsh, M. A., Rather, P. N., & Blackwell, H. E. (2012) · ACS Chemical Biology · doi:10.1021/cb300351x · Cited by 113
The agr Locus Regulates Virulence and Colonization Genes in Clostridium difficile 027
Martin, M. J., Clare, S., Goulding, D., Faulds‐Pain, A., Barquist, L., Browne, H. P., Pettit, L. J., Dougan, G., Lawley, T. D., & Wren, B. W. (2013) · Journal of Bacteriology · doi:10.1128/jb.00473-13 · Cited by 113
García‐Contreras, R., Martínez‐Vázquez, M., Velázquez‐Guadarrama, N., Pañeda, A. G. V., Hashimoto, T., Maeda, T., Quezada, H., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12039 · Cited by 104
Can resistance against quorum-sensing interference be selected?
García‐Contreras, R., Maeda, T., & Wood, T. K. (2015) · The ISME Journal · doi:10.1038/ismej.2015.84 · Cited by 102
Chorell, E., Pinkner, J. S., Phan, G., Edvinsson, S., Buelens, F. P., Remaut, H. K., Waksman, G., Hultgren, S. J., & Almqvist, F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100470t · Cited by 95
Antibacterial monoclonal antibodies: the next generation?
DiGiandomenico, A., & Sellman, B. R. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.014 · Cited by 93
Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection
Subashchandrabose, S., Smith, S., DeOrnellas, V., Crepin, S., Kole, M., Zahdeh, C., & Mobley, H. L. T. (2016) · mSphere · doi:10.1128/msphere.00013-15 · Cited by 93
Vancomycin resistant Staphylococcus aureus in the United States
Woodford, N. (2002) · Weekly releases (1997–2007) · doi:10.2807/esw.06.28.01913-en · Cited by 91
Mechanisms of Neutralization of a Human Anti-α-toxin Antibody
Oganesyan, V., Peng, L., Damschroder, M. M., Li, C., Sadowska, A., Tkaczyk, C., Sellman, B. R., Wu, H., & Dall’Acqua, W. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601328 · Cited by 86
Wang, Q., Chang, C.-S., Pennini, M. E., Pelletier, M. R., Rajan, S., Zha, J., Chen, Y., Cvitkovic, R., Sadowska, A., Thompson, J. H., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw021 · Cited by 86
Bacteremia complicating gram-negative urinary tract infections: A population-based study
Al‐Hasan, M. N., Eckel‐Passow, J. E., & Baddour, L. M. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.01.007 · Cited by 83
de Léséleuc, L., Harris, G., KuoLee, R., & Chen, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-12 · Cited by 82
van Tiel-Menkveld, G. J., Mentjox-Vervuurt, J. M., Oudega, B., & de Graaf, F. K. (1982) · Journal of Bacteriology · doi:10.1128/jb.150.2.490-497.1982 · Cited by 80
Pilicide ec240 Disrupts Virulence Circuits in Uropathogenic Escherichia coli
Greene, S. E., Pinkner, J. S., Chorell, E., Dodson, K., Shaffer, C. L., Conover, M. S., Livny, J., Hadjifrangiskou, M., Almqvist, F., & Hultgren, S. J. (2014) · mBio · doi:10.1128/mbio.02038-14 · Cited by 79
Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii
Chabane, Y. N., Mlouka, M. A. B., Alexandre, S., Nicol, M., Martí, S., Pestel‐Caron, M., Vilà, J., Jouenne, T., & Dé, E. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-62 · Cited by 75
Antibody-Based Therapy for Enterococcal Catheter-Associated Urinary Tract Infections
Flores‐Mireles, A. L., Walker, J. N., Potretzke, A. M., Schreiber, H. L., Pinkner, J. S., Bauman, T. M., Park, A. M., Desai, A. C., Hultgren, S. J., & Caparon, M. G. (2016) · mBio · doi:10.1128/mbio.01653-16 · Cited by 74
Zhu, J., & Kaufmann, G. F. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.07.003 · Cited by 67
Kisiela, D., Avagyan, H., Friend, D. J., Aachal, J., Gupta, S., Interlandi, G., Liu, Y., Tchesnokova, V. L., Rodriguez, V. B., Sumida, J. P., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004857 · Cited by 64
Eibergen, N. R., Moore, J. D., Mattmann, M. E., & Blackwell, H. E. (2015) · ChemBioChem · doi:10.1002/cbic.201500357 · Cited by 60
Darkoh, C., Odo, C., & DuPont, H. L. (2016) · mBio · doi:10.1128/mbio.01237-16 · Cited by 60
Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains
Gilmore, M. S., Rauch, M., Ramsey, M. M., Himes, P., Varahan, S., Manson, J. M., Lebreton, F., & Hancock, L. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500553112 · Cited by 59
Kai, T., Tateda, K., Kimura, S., et al. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.04.004 · Cited by 58
Probert, W. S., McQuaid, C., & Schrader, K. N. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00338-14 · Cited by 56
Crémet, L., Bourigault, C., Lepelletier, D., Guillouzouic, A., Juvin, M. E., Reynaud, A., Corvec, S., & Caroff, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr547 · Cited by 52
Development of a Peptide Antagonist against fsr Quorum Sensing of Enterococcus faecalis
Nakayama, J., Yokohata, R., Sato, M., Suzuki, T., Matsufuji, T., Nishiguchi, K., Kawai, T., Yamanaka, Y., Nagata, K., Tanokura, M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb300717f · Cited by 52
Sharma‐Kuinkel, B. K., Wu, Y., Tabor, D. E., Mok, H., Sellman, B. R., Jenkins, A. L., Yu, L., Jafri, H. S., Rude, T. H., Ruffin, F., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02023-14 · Cited by 52
Li, M., Dai, Y., Zhu, Y., Fu, C.-L., Tan, V. Y., Wang, Y., Wang, X., Hong, X., Liu, Q., Li, T., et al. (2016) · Scientific Reports · doi:10.1038/srep27899 · Cited by 49
Self-citationYamamoto, B., Shadiack, A. M., Carpenter, S., Sanford, D., Henning, L. N., Gonzales, N., O'Connor, E., Casey, L. S., & Serbina, N. V. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-16 · Cited by 49
Multidrug-ResistantStaphylococcus aureus, India, 2013–2015
Kumar, M. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.160044 · Cited by 48
Badarau, A., Rouha, H., Malafa, S., Battles, M. B., Walker, L. M., Nielson, N., Doležílková, I., Teubenbacher, A., Banerjee, S., Maierhofer, B., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1215791 · Cited by 48
Kozel, T. R., Thorkildson, P., Brandt, S., Welch, W. H., Lovchik, J. A., AuCoin, D. P., Vilai, J., & Lyons, C. R. (2006) · Infection and Immunity · doi:10.1128/iai.01133-06 · Cited by 47
Desouky, S. E., Shojima, A., Singh, R. P., Matsufuji, T., Igarashi, Y., Suzuki, T., Yamagaki, T., Okubo, K.-I., Ohtani, K., Sonomoto, K., et al. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv109 · Cited by 47
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii
García‐Quintanilla, M., Caro‐Vega, J. M., Pulido, M. R., Moreno-Martínez, P., Pachón, J., & McConnell, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00407-16 · Cited by 44
Involvement of curli fimbriae in the biofilm formation of Enterobacter cloacae
Kim, S., Lee, H.-W., Choi, Y.-W., Kim, S., Lee, J. C., Lee, Y.-C., Seol, S. Y., Cho, D.-T., & Kim, J. (2012) · The Journal of Microbiology · doi:10.1007/s12275-012-2044-2 · Cited by 43
Williams, J. D., Torhan, M. C., Neelagiri, V. R., Brown, C. L., Bowlin, N. O., Di, M., McCarthy, C. T., Aiello, D. A., Peet, N. P., Bowlin, T. L., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.011 · Cited by 40
Designing inhibitors of anthrax toxin
Nestorovich, E. M., & Bezrukov, S. M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.877884 · Cited by 37
Mavroidi, A., Likousi, S., Palla, E., et al. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000127 · Cited by 32
Anantharajah, A., Faure, E., Buyck, J. M., Sundin, C., Lindmark, T., Mecsas, J. C., Yahr, T. L., Tulkens, P. M., Mingeot‐Leclercq, M., Guery, B. P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw295 · Cited by 30
Chen, Y., Chatterjee, S. S., Porcella, S. F., Yu, Y., & Otto, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072803 · Cited by 25
Self-citation
Cited by
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Self-citationHorcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Metadata
- Authors
- Dickey, S. W., Cheung, G. Y. C., & Otto, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2017-03-24
- Volume
- 16
- Issue
- 7
- Pages
- 457-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2598898392
- Cited by
- 799
- References
- 163
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.